Back to RecallTracker
Health Canada Health products

Octreotide for injectable suspension; Good manufacturing practices concerns

Issued January 13, 2026
Issue
Quality concerns of affected lots due to deficiencies in Good Manufacturing Practices (GMP).
Hazard description
Product quality
What to do
If you have an affected product, do not use it. Speak to your health care professional immediately to obtain an alternative or replacement product. If you are unsure whether your product is affected, check with your pharmacy. Seek medical attention if you have used this product and are experiencing symptoms of infection, or other unexpected symptoms or side effects. Return affected product(s) to the pharmacy where it was purchased for proper disposal. Consult a health care professional if you have used the affected product and have health concerns. Contact Teva Canada Limited by calling toll-free at 1-800-268-4127, option 3, or by email at druginfo@tevacanada.com , if you have questions about this recall. Report any health product-related side effects or complaints to Health Canada.
Product
Product name
Octreotide for injectable suspension
Reference
ID
RA-81480